@therestoreclinic's TRT protocol question, fact-checked

What did @therestoreclinic actually say?

The creator, who identifies as a TRT patient himself, asked viewers to share their dosing protocols. He disclosed his own: "50 milligrams Monday, Wednesday, Friday," which he says puts him at around 1,000 ng/dL total testosterone. He also pushed back on lab-centric thinking, arguing that "it's not necessarily about how your labs look" but rather how a patient responds and what symptomatic relief they experience. He also characterized the stigma around TRT as "unwarranted."

That is the full substance of the video. There are no dramatic medical claims here, no disease cures promised, no specific treatment recommendations directed at viewers. It is largely a personal disclosure paired with a philosophical stance on how TRT outcomes should be measured.

Does the science back this up?

Partially, yes. The symptoms-over-numbers argument has real clinical support, but it is not the whole picture. Labs still matter, especially for safety monitoring.

The Endocrine Society's 2018 clinical practice guidelines (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism) do acknowledge that symptom resolution is a primary treatment goal. Men with low testosterone who report fatigue, low libido, and mood changes are expected to see improvement, and those subjective outcomes matter. A 2020 review by Rastrelli and Maggi in Best Practice and Research: Clinical Endocrinology and Metabolism reinforced that symptom burden often correlates poorly with serum testosterone levels alone, meaning two men with identical lab values can have very different clinical pictures.

That said, labs are not optional extras. Hematocrit, PSA, estradiol, and LH suppression all need monitoring on TRT. Dismissing labs entirely would be a clinical mistake, even if the creator did not quite go that far.

What did they get wrong (or right)?

The "how you respond" framing is mostly right, but the phrasing "it's not necessarily about how your labs look" risks being taken out of context by viewers who might use it to justify avoiding follow-up bloodwork altogether. That would be a problem.

On the dosing disclosure: 150 mg of testosterone per week split into three injections is a common, mid-range TRT protocol. A resulting total testosterone of approximately 1,000 ng/dL sits within the upper-normal reference range (generally 300 to 1,000 ng/dL per most U.S. lab standards). None of that is unusual or alarming. It is not a dose recommendation for viewers, it is a personal data point, and that distinction matters.

On stigma: the claim that TRT stigma is "unwarranted" is defensible in the context of medically supervised hypogonadism treatment. The stigma largely bleeds over from non-medical performance-enhancing use, which is a different thing entirely. Conflating the two does a disservice to patients with legitimate deficiencies.

What should you actually know?

If you are considering TRT, a few things deserve more airtime than this video gave them.

• Baseline labs are not bureaucratic box-checking. They establish whether you actually have low testosterone and catch contraindications like elevated hematocrit or untreated sleep apnea.
• Ongoing monitoring matters. Hematocrit can rise on TRT and increase clotting risk. Estradiol conversion from exogenous testosterone is real and can cause symptoms at high levels. Per Bhasin et al. (2018), monitoring at 3 and 12 months after initiation is standard of care.
• "Cruising at 1,000" is not a universal target. Reference ranges vary by lab, and some men feel best at levels other practices would consider suboptimal. That is exactly the symptom-response argument the creator is making, and it is a valid one when paired with proper oversight.
• Injection frequency affects stability. Three times per week injections, as described here, produce more stable serum levels than once-weekly dosing, which is supported by pharmacokinetic data on testosterone cypionate (Shoskes et al., 2016, Translational Andrology and Urology).

Bottom line

This video is relatively low-harm for TRT content. The creator is not selling a protocol or making therapeutic claims for viewers. He is sharing his own experience and raising a legitimate clinical point about symptom response. The one place to push back is the framing that labs are secondary. They are not secondary. They are a parallel input that responsible TRT management requires, not a bureaucratic obstacle to ignore once you feel good.